Christopher Demuth Sharp, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sharp’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A69330 · Current
Licensed to practise in California · since 1999 · expires 2029-01-31 · Dartmouth Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$14,773
Medicare paid this office $14,773 for 98 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $3,328 | $71 |
| Return visit (30+ min) | 36 | $2,551 | $52 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $2,247 | $61 |
| Hospital discharge day management, 30 minutes or less | 15 | $1,117 | $74 |
| Short return visit (20+ min) | 14 | $817 | $51 |
See all 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $3,328 | $71 |
| Return visit (30+ min) | 36 | $2,551 | $52 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $2,247 | $61 |
| Hospital discharge day management, 30 minutes or less | 15 | $1,117 | $74 |
| Short return visit (20+ min) | 14 | $817 | $51 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 12 | $225 | $15 |
Who their Medicare patients are
98 Original Medicare patients in 2024. Average age 75 · Women 43% · Also on Medicaid 27% · Health risk score 1.85. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 62% · Chronic kidney disease 29% · Diabetes 28% · Atrial fibrillation 23% · Depression 21% · Coronary heart disease 20% · Heart failure 19% · Cancer 16% · Dementia 14% · COPD 13%.
The office billed $82,246, Medicare allowed $19,604 and paid $14,773; for 238 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 98 | 238 | 75 | 1.85 | $82,246 | $14,773 |
| 2023 | 100 | 229 | 77 | 1.67 | $80,343 | $14,181 |
| 2022 | 91 | 207 | 75 | 1.67 | $70,346 | $13,227 |
| 2021 | 100 | 227 | 75 | 1.95 | $78,648 | $15,152 |
| 2020 | 93 | 200 | 74 | 1.71 | $63,587 | $15,050 |
| 2019 | 80 | 147 | 76 | 1.25 | $26,917 | $10,976 |
| 2018 | 88 | 185 | 76 | 1.23 | $38,131 | $13,600 |
| 2017 | 93 | 242 | 75 | 1.71 | $57,991 | $16,608 |
| 2016 | 82 | 179 | 75 | 1.61 | $43,990 | $12,204 |
| 2015 | 122 | 285 | 73 | 1.71 | $77,533 | $21,823 |
| 2014 | 82 | 154 | 75 | 1.05 | $37,406 | $10,731 |
| 2013 | 113 | 245 | 74 | 1.34 | $60,743 | $17,167 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 30 | $2,746 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $2,709 | $71 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 45 | $2,395 | $53 |
| Short return visit (20+ min) | 23 | $1,572 | $49 |
| Long return visit (40+ min) | 13 | $971 | $65 |
| Hospital discharge day management, 30 minutes or less | 13 | $964 | $74 |
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,848 | $65 |
| Return visit (30+ min) | 27 | $2,045 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,956 | $122 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 29 | $1,634 | $56 |
| Short return visit (20+ min) | 14 | $813 | $51 |
2021: 5 services
| Return visit (30+ min) | 36 | $2,895 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,324 | $66 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 32 | $1,865 | $58 |
| Long return visit (40+ min) | 20 | $1,722 | $64 |
| Short return visit (20+ min) | 16 | $1,142 | $48 |
2020: 5 services
| Return visit (30+ min) | 45 | $3,969 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $2,337 | $67 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,576 | $143 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $905 | $75 |
| Hospital discharge day management, 30 minutes or less | 13 | $893 | $69 |
2019: 3 services
| Return visit (30+ min) | 52 | $5,984 | $66 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,117 | $141 |
| Short return visit (20+ min) | 12 | $604 | $40 |
2018: 5 services
| Return visit (30+ min) | 40 | $3,948 | $60 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,965 | $140 |
| Return visit (30+ min) | 24 | $1,766 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,344 | $122 |
| Short return visit (20+ min) | 13 | $599 | $35 |
2017: 7 services
| Return visit (30+ min) | 44 | $5,202 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,980 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,197 | $122 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,939 | $139 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,325 | $66 |
| Short return visit (20+ min) | 19 | $867 | $38 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $629 | $35 |
2016: 6 services
| Return visit (30+ min) | 44 | $5,201 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,514 | $138 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,458 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $900 | $64 |
| Short return visit (20+ min) | 20 | $873 | $38 |
| Hospital discharge day management, 30 minutes or less | 12 | $789 | $66 |
2015: 7 services
| Return visit (30+ min) | 55 | $5,929 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,492 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,943 | $118 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,796 | $138 |
| Hospital discharge day management, 30 minutes or less | 25 | $1,657 | $66 |
| Long return visit (40+ min) | 11 | $1,489 | $88 |
| Short return visit (20+ min) | 14 | $591 | $39 |
2014: 2 services
| Return visit (30+ min) | 59 | $6,408 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | $1,887 | $135 |
2013: 4 services
| Return visit (30+ min) | 70 | $8,113 | $59 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,001 | $133 |
| Long return visit (40+ min) | 13 | $1,296 | $72 |
| Short return visit (20+ min) | 13 | $488 | $38 |
Medicaid work
$570 in 2021
Medicaid paid $570 for 26 billed services this clinician did in 2021, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 26 | $570 |
| 2021 | 26 | 1 | 12 | $570 |
| 2018 | 13 | 1 | 13 | $929 |
See the largest Medicaid services in earlier years
2018
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 13 | $929 |
Drugs they prescribed that Part D paid
$107,204
Pharmacies billed $107,204 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
809 generic and fewer than 11 brand-name prescriptions · $107,204 in drug cost · 14 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 30 | $31,016 | $1,034 |
| Jardiance | 17 | $29,341 | $1,726 |
| Breo Ellipta | 13 | $5,474 | $421 |
| Ketorolac Tromethamine | 14 | $2,035 | $145 |
| Rosuvastatin | 47 | $1,354 | $29 |
See all 29 drugs
| Eliquis | 30 | $31,016 | $1,034 |
| Jardiance | 17 | $29,341 | $1,726 |
| Breo Ellipta | 13 | $5,474 | $421 |
| Ketorolac Tromethamine | 14 | $2,035 | $145 |
| Rosuvastatin | 47 | $1,354 | $29 |
| Tamsulosin | 30 | $921 | $31 |
| Gabapentin | 18 | $882 | $49 |
| Diphenhydramine | 12 | $681 | $57 |
| Zolpidem Tartrate Er | 19 | $558 | $29 |
| Atorvastatin | 65 | $533 | $8 |
| Lisinopril | 35 | $518 | $15 |
| Propranolol Hcl Er | 11 | $482 | $44 |
| Hydralazine | 17 | $470 | $28 |
| Omeprazole | 27 | $422 | $16 |
| Metoprolol | 15 | $400 | $27 |
| Metformin | 24 | $348 | $15 |
| Escitalopram | 17 | $333 | $20 |
| Allopurinol | 13 | $264 | $20 |
| Levothyroxine | 11 | $258 | $23 |
| Losartan | 23 | $253 | $11 |
| Fluticasone Propionate | 11 | $228 | $21 |
| Zolpidem | 19 | $201 | $11 |
| Amlodipine Besylate | 35 | $181 | $5 |
| Trazodone | 11 | $172 | $16 |
| Lorazepam | 26 | $159 | $6 |
| Triamterene-Hydrochlorothiazid | 22 | $157 | $7 |
| Mirtazapine | 12 | $143 | $12 |
| Furosemide | 17 | $121 | $7 |
| Pantoprazole | 12 | $118 | $10 |
Year by year
| 2024 | 909 | 88 | None | None | $107,204 |
| 2023 | 867 | 90 | None | 12% | $125,295 |
| 2022 | 828 | 88 | 9% (70) | None | $117,599 |
| 2021 | 865 | 82 | 11% (98) | None | $85,297 |
| 2020 | 921 | 85 | 12% (109) | None | $93,067 |
| 2019 | 885 | 69 | 12% (102) | None | $77,455 |
| 2018 | 871 | 86 | 8% (65) | None | $67,292 |
| 2017 | 1,030 | 86 | 5% (54) | None | $75,922 |
| 2016 | 1,022 | 93 | 4% (45) | None | $61,890 |
| 2015 | 912 | 85 | 5% (46) | None | $55,692 |
| 2014 | 919 | 70 | 5% (50) | 16% | $51,101 |
| 2013 | 969 | 93 | 8% (75) | 18% | $61,581 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Eliquis | 31 | $30,778 | $993 |
| Jardiance | 16 | $28,153 | $1,760 |
| Rosuvastatin | 43 | $1,447 | $34 |
| Gabapentin | 16 | $1,127 | $70 |
| Atorvastatin | 57 | $985 | $17 |
| Zolpidem Tartrate Er | 15 | $695 | $46 |
| Omeprazole | 22 | $685 | $31 |
| Tamsulosin | 25 | $681 | $27 |
| Triamterene-Hydrochlorothiazid | 28 | $629 | $22 |
| Metformin | 35 | $593 | $17 |
| Losartan | 29 | $543 | $19 |
| Lisinopril | 32 | $460 | $14 |
| Amlodipine Besylate | 38 | $408 | $11 |
| Fluticasone Propionate | 16 | $371 | $23 |
| Simvastatin | 15 | $302 | $20 |
| Levothyroxine | 12 | $293 | $24 |
| Lorazepam | 28 | $257 | $9 |
| Pantoprazole | 14 | $184 | $13 |
| Zolpidem | 15 | $181 | $12 |
| Hydralazine | 16 | $170 | $11 |
| Furosemide | 12 | $57 | $5 |
| Mirtazapine | 13 | $53 | $4 |
2022: 22 drugs
| Jardiance | 16 | $27,257 | $1,704 |
| Eliquis | 26 | $23,662 | $910 |
| Oxycodone | 53 | $2,438 | $46 |
| Famotidine | 28 | $2,279 | $81 |
| Rosuvastatin | 35 | $1,880 | $54 |
| Diltiazem 24hr Er (Cd) | 14 | $1,001 | $72 |
| Atorvastatin | 44 | $665 | $15 |
| Tamsulosin | 20 | $628 | $31 |
| Triamterene-Hydrochlorothiazid | 23 | $406 | $18 |
| Amlodipine Besylate | 28 | $394 | $14 |
| Losartan | 24 | $377 | $16 |
| Omeprazole | 15 | $348 | $23 |
| Lisinopril | 36 | $346 | $10 |
| Metformin | 22 | $329 | $15 |
| Levothyroxine | 17 | $242 | $14 |
| Simvastatin | 18 | $222 | $12 |
| Pantoprazole | 24 | $207 | $9 |
| Finasteride | 11 | $199 | $18 |
| Zolpidem Tartrate Er | 17 | $182 | $11 |
| Zolpidem | 16 | $149 | $9 |
| Lorazepam | 21 | $123 | $6 |
| Alendronate | 11 | $104 | $9 |
2021: 26 drugs
| Oxycodone | 67 | $3,779 | $56 |
| Famotidine | 16 | $3,123 | $195 |
| Rosuvastatin | 27 | $1,492 | $55 |
| Oxycodone-Acetaminophen | 11 | $1,156 | $105 |
| Gabapentin | 11 | $1,014 | $92 |
| Atorvastatin | 50 | $1,009 | $20 |
| Fentanyl | 11 | $909 | $83 |
| Chlorthalidone | 14 | $723 | $52 |
| Levothyroxine | 30 | $712 | $24 |
| Baclofen | 12 | $581 | $48 |
| Lisinopril | 47 | $571 | $12 |
| Tamsulosin | 22 | $528 | $24 |
| Omeprazole | 22 | $475 | $22 |
| Metformin | 24 | $445 | $19 |
| Triamterene-Hydrochlorothiazid | 25 | $432 | $17 |
| Amlodipine Besylate | 41 | $430 | $10 |
| Pantoprazole | 21 | $424 | $20 |
| Zolpidem Tartrate Er | 20 | $378 | $19 |
| Ondansetron | 11 | $355 | $32 |
| Simvastatin | 16 | $321 | $20 |
| Losartan | 11 | $305 | $28 |
| Trazodone | 11 | $272 | $25 |
| Pravastatin | 13 | $249 | $19 |
| Zolpidem | 17 | $147 | $9 |
| Alendronate | 18 | $129 | $7 |
| Lorazepam | 21 | $91 | $4 |
2020: 22 drugs
| Oxycodone | 69 | $5,263 | $76 |
| Oxycodone-Acetaminophen | 12 | $2,122 | $177 |
| Fentanyl | 12 | $1,272 | $106 |
| Atorvastatin | 51 | $1,214 | $24 |
| Chlorthalidone | 15 | $947 | $63 |
| Levothyroxine | 26 | $711 | $27 |
| Fluticasone Propionate | 17 | $653 | $38 |
| Metformin | 25 | $588 | $24 |
| Rosuvastatin | 14 | $533 | $38 |
| Lisinopril | 32 | $459 | $14 |
| Mirtazapine | 11 | $438 | $40 |
| Amlodipine Besylate | 49 | $431 | $9 |
| Ondansetron | 12 | $417 | $35 |
| Tamsulosin | 18 | $414 | $23 |
| Triamterene-Hydrochlorothiazid | 32 | $409 | $13 |
| Pravastatin | 20 | $301 | $15 |
| Simvastatin | 18 | $289 | $16 |
| Omeprazole | 24 | $289 | $12 |
| Finasteride | 12 | $278 | $23 |
| Doxepin | 12 | $132 | $11 |
| Alendronate | 15 | $58 | $4 |
| Pantoprazole | 11 | $54 | $5 |
2019: 25 drugs
| Oxycodone | 55 | $4,246 | $77 |
| Uloric | 12 | $4,164 | $347 |
| Humalog Kwikpen U-100 | 12 | $2,274 | $189 |
| Oxycodone-Acetaminophen | 14 | $1,235 | $88 |
| Atorvastatin | 50 | $1,095 | $22 |
| Lidocaine | 13 | $666 | $51 |
| Lisinopril | 30 | $477 | $16 |
| Ondansetron | 15 | $462 | $31 |
| Levothyroxine | 13 | $426 | $33 |
| Simvastatin | 19 | $373 | $20 |
| Tamsulosin | 15 | $355 | $24 |
| Triamterene-Hydrochlorothiazid | 22 | $351 | $16 |
| Chlorthalidone | 11 | $343 | $31 |
| Metformin | 23 | $334 | $15 |
| Amlodipine Besylate | 45 | $312 | $7 |
| Finasteride | 11 | $226 | $21 |
| Pantoprazole | 11 | $198 | $18 |
| Baclofen | 14 | $198 | $14 |
| Omeprazole | 24 | $187 | $8 |
| Losartan | 12 | $174 | $15 |
| Pravastatin | 18 | $136 | $8 |
| Furosemide | 11 | $118 | $11 |
| Lorazepam | 13 | $109 | $8 |
| Doxepin | 13 | $93 | $7 |
| Alendronate | 17 | $43 | $3 |
2018: 30 drugs
| Oxycodone | 17 | $2,257 | $133 |
| Lidocaine | 13 | $1,671 | $129 |
| Atorvastatin | 53 | $1,666 | $31 |
| Doxazosin Mesylate | 12 | $1,385 | $115 |
| Oxycodone-Acetaminophen | 13 | $1,074 | $83 |
| Tamsulosin | 16 | $822 | $51 |
| Zolpidem Tartrate Er | 18 | $567 | $32 |
| Baclofen | 14 | $504 | $36 |
| Levothyroxine | 13 | $491 | $38 |
| Rosuvastatin | 13 | $476 | $37 |
| Ondansetron | 11 | $470 | $43 |
| Felodipine Er | 11 | $463 | $42 |
| Fluticasone Propionate | 11 | $445 | $40 |
| Triamterene-Hydrochlorothiazid | 19 | $426 | $22 |
| Pantoprazole | 14 | $355 | $25 |
| Lisinopril | 32 | $344 | $11 |
| Amlodipine Besylate | 41 | $320 | $8 |
| Metformin | 25 | $315 | $13 |
| Simvastatin | 21 | $273 | $13 |
| Pravastatin | 19 | $271 | $14 |
| Zolpidem | 13 | $270 | $21 |
| Losartan | 19 | $240 | $13 |
| Omeprazole | 32 | $231 | $7 |
| Prochlorperazine Maleate | 12 | $154 | $13 |
| Atenolol | 11 | $151 | $14 |
| Furosemide | 13 | $151 | $12 |
| Doxepin | 12 | $137 | $11 |
| Alendronate | 19 | $124 | $7 |
| Hydrochlorothiazide | 20 | $93 | $5 |
| Lorazepam | 21 | $90 | $4 |
2017: 36 drugs
| Atorvastatin | 53 | $1,705 | $32 |
| Oxycodone-Acetaminophen | 22 | $1,644 | $75 |
| Proair Hfa | 14 | $1,631 | $117 |
| Zolpidem Tartrate Er | 17 | $926 | $54 |
| Doxazosin Mesylate | 11 | $793 | $72 |
| Nitrostat | 17 | $793 | $47 |
| Tamsulosin | 15 | $775 | $52 |
| Rosuvastatin | 11 | $763 | $69 |
| Pravastatin | 25 | $749 | $30 |
| Levothyroxine | 26 | $673 | $26 |
| Felodipine Er | 11 | $661 | $60 |
| Chlorthalidone | 11 | $583 | $53 |
| Fluticasone Propionate | 13 | $533 | $41 |
| Doxepin | 16 | $477 | $30 |
| Memantine | 16 | $463 | $29 |
| Gabapentin | 15 | $460 | $31 |
| Zolpidem | 13 | $441 | $34 |
| Amlodipine Besylate | 48 | $371 | $8 |
| Triamterene-Hydrochlorothiazid | 15 | $361 | $24 |
| Methadone | 11 | $320 | $29 |
| Omeprazole | 41 | $311 | $8 |
| Simvastatin | 24 | $306 | $13 |
| Metformin | 22 | $284 | $13 |
| Losartan | 19 | $265 | $14 |
| Lisinopril | 22 | $263 | $12 |
| Pantoprazole | 11 | $231 | $21 |
| Hydrochlorothiazide | 44 | $196 | $4 |
| Furosemide | 19 | $190 | $10 |
| Prednisone | 14 | $187 | $13 |
| Valsartan | 14 | $176 | $13 |
| Alendronate | 20 | $168 | $8 |
| Escitalopram | 19 | $161 | $8 |
| Metoprolol | 13 | $157 | $12 |
| Atenolol | 13 | $127 | $10 |
| Prochlorperazine Maleate | 12 | $96 | $8 |
| Lorazepam | 17 | $66 | $4 |
2016: 33 drugs
| Oxycodone-Acetaminophen | 19 | $3,027 | $159 |
| Atorvastatin | 50 | $1,724 | $34 |
| Doxazosin Mesylate | 13 | $1,021 | $79 |
| Tamsulosin | 22 | $868 | $39 |
| Nitrostat | 17 | $618 | $36 |
| Gabapentin | 19 | $582 | $31 |
| Doxepin | 18 | $542 | $30 |
| Pantoprazole | 12 | $512 | $43 |
| Pravastatin | 28 | $501 | $18 |
| Zolpidem Tartrate Er | 15 | $465 | $31 |
| Simvastatin | 27 | $449 | $17 |
| Levothyroxine | 19 | $447 | $24 |
| Memantine | 17 | $430 | $25 |
| Methadone | 12 | $388 | $32 |
| Metformin | 25 | $356 | $14 |
| Amlodipine Besylate | 49 | $346 | $7 |
| Losartan | 22 | $315 | $14 |
| Zolpidem | 12 | $307 | $26 |
| Lisinopril | 21 | $300 | $14 |
| Omeprazole | 33 | $298 | $9 |
| Hydrochlorothiazide | 44 | $247 | $6 |
| Triamterene-Hydrochlorothiazid | 11 | $242 | $22 |
| Amitriptyline | 13 | $238 | $18 |
| Bupropion Xl | 13 | $225 | $17 |
| Furosemide | 19 | $211 | $11 |
| Valsartan | 12 | $172 | $14 |
| Metoprolol | 13 | $157 | $12 |
| Alendronate | 20 | $147 | $7 |
| Prochlorperazine Maleate | 11 | $138 | $13 |
| Escitalopram | 17 | $127 | $7 |
| Methocarbamol | 13 | $121 | $9 |
| Atenolol | 16 | $96 | $6 |
| Clonazepam | 13 | $31 | $2 |
2015: 27 drugs
| Crestor | 11 | $4,735 | $430 |
| Oxycodone-Acetaminophen | 16 | $3,585 | $224 |
| Doxazosin Mesylate | 15 | $1,584 | $106 |
| Atorvastatin | 36 | $1,134 | $31 |
| Proair Hfa | 13 | $900 | $69 |
| Levothyroxine | 20 | $695 | $35 |
| Triamterene-Hydrochlorothiazid | 31 | $654 | $21 |
| Losartan | 45 | $547 | $12 |
| Omeprazole | 31 | $529 | $17 |
| Methadone | 11 | $517 | $47 |
| Pravastatin | 18 | $434 | $24 |
| Nitrostat | 16 | $379 | $24 |
| Doxepin | 17 | $370 | $22 |
| Metoprolol | 12 | $329 | $27 |
| Fluticasone Propionate | 12 | $267 | $22 |
| Simvastatin | 23 | $228 | $10 |
| Hydrochlorothiazide | 33 | $224 | $7 |
| Metformin | 27 | $221 | $8 |
| Amlodipine Besylate | 39 | $210 | $5 |
| Lisinopril | 18 | $185 | $10 |
| Furosemide | 27 | $180 | $7 |
| Alendronate | 19 | $145 | $8 |
| Lorazepam | 16 | $137 | $9 |
| Escitalopram | 13 | $72 | $6 |
| Prochlorperazine Maleate | 12 | $59 | $5 |
| Zolpidem | 13 | $52 | $4 |
| Clonazepam | 11 | $26 | $2 |
2014: 30 drugs
| Zetia | 14 | $3,774 | $270 |
| Diovan | 11 | $1,444 | $131 |
| Butalb-Caff-Acetaminoph-Codein | 11 | $1,117 | $102 |
| Doxazosin Mesylate | 12 | $1,064 | $89 |
| Atorvastatin | 20 | $951 | $48 |
| Metoprolol | 24 | $558 | $23 |
| Triamterene-Hydrochlorothiazid | 34 | $556 | $16 |
| Losartan | 18 | $422 | $23 |
| Simvastatin | 37 | $415 | $11 |
| Lisinopril | 48 | $411 | $9 |
| Fluticasone Propionate | 14 | $399 | $29 |
| Omeprazole | 25 | $371 | $15 |
| Levothyroxine | 16 | $364 | $23 |
| Metformin | 23 | $362 | $16 |
| Alendronate | 30 | $313 | $10 |
| Tamsulosin | 13 | $306 | $24 |
| Nitrostat | 17 | $245 | $14 |
| Amlodipine Besylate | 55 | $243 | $4 |
| Doxepin | 14 | $234 | $17 |
| Lorazepam | 20 | $206 | $10 |
| Hydromorphone | 11 | $204 | $19 |
| Hydrochlorothiazide | 30 | $179 | $6 |
| Trazodone | 12 | $152 | $13 |
| Glipizide | 13 | $134 | $10 |
| Furosemide | 17 | $118 | $7 |
| Warfarin | 13 | $111 | $9 |
| Ranitidine | 12 | $107 | $9 |
| Escitalopram | 13 | $100 | $8 |
| Atenolol | 17 | $93 | $5 |
| Clonazepam | 11 | $53 | $5 |
2013: 26 drugs
| Zetia | 15 | $3,678 | $245 |
| Crestor | 11 | $3,368 | $306 |
| Atorvastatin | 20 | $1,396 | $70 |
| Metoprolol | 32 | $1,067 | $33 |
| Omeprazole | 32 | $833 | $26 |
| Simvastatin | 38 | $484 | $13 |
| Losartan | 30 | $466 | $16 |
| Hydrocodone-Acetaminophen | 31 | $461 | $15 |
| Lisinopril | 45 | $451 | $10 |
| Triamterene-Hctz | 23 | $416 | $18 |
| Tamsulosin | 17 | $339 | $20 |
| Methadone | 11 | $331 | $30 |
| Hydralazine | 11 | $328 | $30 |
| Levothyroxine | 25 | $326 | $13 |
| Metformin | 20 | $317 | $16 |
| Ranitidine | 13 | $285 | $22 |
| Amlodipine Besylate | 42 | $282 | $7 |
| Hydrochlorothiazide | 32 | $276 | $9 |
| Glipizide | 12 | $215 | $18 |
| Furosemide | 23 | $191 | $8 |
| Atenolol | 24 | $182 | $8 |
| Lorazepam | 12 | $148 | $12 |
| Nitrostat | 12 | $133 | $11 |
| Escitalopram | 13 | $130 | $10 |
| Alendronate | 19 | $127 | $7 |
| Zolpidem | 19 | $68 | $4 |
Money from drug and device companies
$100 in 2025
| 2025 | 1 | 1 | None | $100 |
| 2021 | 1 | 1 | None | $98 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Baxter Healthcare | None | $100 | 1 payment
|
See the published payment
| Baxter Healthcare | Meals · 2025-04-23 | None | $100 |
See earlier years (2021)
2021: $98
| Siemens Medical Solutions USA | None | $98 | 1 payment
|
Professional record
- NPI
- 1003996935
- Licence
- CA A69330California A69330: Current · expires 2029-01-31
- Trained
- Geisel School of Medicine at Dartmouth, 1998
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 2083C0008X (2083C0008X)
- Mailing address
- 300 Pasteur Dr Ste 301, Stanford, CA, 94305
- NPI first listed
- 2006-10-16
- NPI last updated
- 2024-04-23
- NPI record certified
- 2024-04-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 211 Quarry Rd, Palo Alto, CA, 94304 · 900 Blake Wilbur Dr, Palo Alto, CA, 94304